{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:47:39Z","timestamp":1790948859905,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100007642","name":"Universit\u00e0 degli Studi di Roma Tor Vergata","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007642","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Diagn Ther"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s40291-025-00778-6","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T15:47:30Z","timestamp":1745336850000},"page":"435-442","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["FAPI-Targeted Molecular Imaging: Transforming Insights into Post-Ischemic Myocardial Remodeling?"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4423-5496","authenticated-orcid":false,"given":"Luca","family":"Filippi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3073-9377","authenticated-orcid":false,"given":"Marco Alfonso","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6176-2805","authenticated-orcid":false,"given":"Orazio","family":"Schillaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"key":"778_CR1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.addr.2019.05.011","volume":"146","author":"S Hinderer","year":"2019","unstructured":"Hinderer S, Schenke-Layland K. Cardiac fibrosis\u2014a short review of causes and therapeutic strategies. Adv Drug Deliv Rev. 2019;146:77\u201382.","journal-title":"Adv Drug Deliv Rev"},{"key":"778_CR2","doi-asserted-by":"publisher","first-page":"11747","DOI":"10.3390\/ijms252111747","volume":"25","author":"E Fiorino","year":"2024","unstructured":"Fiorino E, Rossin D, Vanni R, Aubry M, Giachino C, Rastaldo R. Recent insights into endogenous mammalian cardiac regeneration post-myocardial infarction. IJMS. 2024;25:11747.","journal-title":"IJMS."},{"key":"778_CR3","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41569-022-00823-5","volume":"20","author":"J Yap","year":"2023","unstructured":"Yap J, Irei J, Lozano-Gerona J, Vanapruks S, Bishop T, Boisvert WA. Macrophages in cardiac remodelling after myocardial infarction. Nat Rev Cardiol. 2023;20:373\u201385.","journal-title":"Nat Rev Cardiol"},{"key":"778_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s44303-024-00053-z","volume":"2","author":"Y Mori","year":"2024","unstructured":"Mori Y, Novruzov E, Schmitt D, Cardinale J, Watabe T, Choyke PL, et al. Clinical applications of fibroblast activation protein inhibitor positron emission tomography (FAPI-PET). npj Imaging. 2024;2:48.","journal-title":"npj Imaging."},{"key":"778_CR5","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.3390\/ijms24043863","volume":"24","author":"MMA Sidrak","year":"2023","unstructured":"Sidrak MMA, De Feo MS, Corica F, Gorica J, Conte M, Filippi L, et al. Fibroblast activation protein inhibitor (FAPI)-based theranostics\u2014where we are at and where we are heading: a systematic review. IJMS. 2023;24:3863.","journal-title":"IJMS."},{"key":"778_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s41181-024-00264-0","volume":"9","author":"A Boschi","year":"2024","unstructured":"Boschi A, Urso L, Uccelli L, Martini P, Filippi L. 99mTc-labeled FAPI compounds for cancer and inflammation: from radiochemistry to the first clinical applications. EJNMMI Radiopharm Chem. 2024;9:36.","journal-title":"EJNMMI Radiopharm Chem."},{"key":"778_CR7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s40336-023-00548-6","volume":"11","author":"F Caobelli","year":"2023","unstructured":"Caobelli F, Nappi C. A spotlight on fibroblast-activated protein inhibitor (FAPi) cardiovascular imaging. Clin Transl Imaging. 2023;11:229\u201333.","journal-title":"Clin Transl Imaging."},{"key":"778_CR8","doi-asserted-by":"publisher","first-page":"1221881","DOI":"10.3389\/fphar.2023.1221881","volume":"14","author":"Z Ren","year":"2023","unstructured":"Ren Z, Zhang Z, Ling L, Liu X, Wang X. Drugs for treating myocardial fibrosis. Front Pharmacol. 2023;14:1221881.","journal-title":"Front Pharmacol"},{"key":"778_CR9","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1053\/j.semnuclmed.2024.02.006","volume":"54","author":"T Higuchi","year":"2024","unstructured":"Higuchi T, Serfling SE, Leistner DM, Speer T, Werner RA. FAPI-PET in cardiovascular disease. Semin Nucl Med. 2024;54:747\u201352.","journal-title":"Semin Nucl Med"},{"key":"778_CR10","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/j.jcmg.2022.06.004","volume":"15","author":"X Wang","year":"2022","unstructured":"Wang X, Guo Y, Gao Y, Ren C, Huang Z, Liu B, et al. Feasibility of 68Ga-labeled fibroblast activation protein inhibitor pet\/ct in light-chain cardiac amyloidosis. JACC Cardiovasc Imaging. 2022;15:1960\u201370.","journal-title":"JACC Cardiovasc Imaging"},{"key":"778_CR11","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s00259-024-06878-5","volume":"52","author":"J Ding","year":"2024","unstructured":"Ding J, Zhang H, Chen X, Wang H, Wang W, You Z, et al. Enhanced detection of damaged myocardium and risk stratification in hypertrophic cardiomyopathy using integrated [68Ga]Ga-FAPI-04 PET\/CMR imaging. Eur J Nucl Med Mol Imaging. 2024;52:98\u2013108.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"778_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.nuclcard.2024.101835","volume":"36","author":"R Solanki","year":"2024","unstructured":"Solanki R, Singh H, Mehta V, Panda P, Singhal M, Sood A, et al. Potential application of 68Ga-FAPI PET\/CT for diagnosing cardiac sarcoidosis. J Nucl Cardiol. 2024;36: 101835.","journal-title":"J Nucl Cardiol"},{"issue":"25","key":"778_CR13","first-page":"00017","volume":"S0914\u20135087","author":"T Nakahara","year":"2025","unstructured":"Nakahara T, Fujimoto S, Jinzaki M. Molecular imaging of cardiovascular disease: current status and future perspective. J Cardiol. 2025;S0914\u20135087(25):00017\u201326.","journal-title":"J Cardiol"},{"key":"778_CR14","doi-asserted-by":"crossref","unstructured":"Loganath K, Craig N, Barton A, Joshi S, Anagnostopoulos C, Erba PA, et al. Cardiovascular positron emission tomography imaging of fibroblast activation: a review of the current literature. J Nucl Cardiol. 2024;102106.","DOI":"10.1016\/j.nuclcard.2024.102106"},{"key":"778_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.614997","volume":"8","author":"D Finke","year":"2021","unstructured":"Finke D, Heckmann MB, Herpel E, Katus HA, Haberkorn U, Leuschner F, et al. Early detection of checkpoint inhibitor-associated myocarditis using 68Ga-FAPI PET\/CT. Front Cardiovasc Med. 2021;8: 614997.","journal-title":"Front Cardiovasc Med."},{"key":"778_CR16","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.2967\/jnumed.122.265147","volume":"64","author":"J Diekmann","year":"2023","unstructured":"Diekmann J, Neuser J, R\u00f6hrich M, Derlin T, Zwadlo C, Koenig T, et al. Molecular imaging of myocardial fibroblast activation in patients with advanced aortic stenosis before transcatheter aortic valve replacement: a pilot study. J Nucl Med. 2023;64:1279\u201386.","journal-title":"J Nucl Med"},{"key":"778_CR17","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.2967\/jnumed.119.226993","volume":"60","author":"Z Varasteh","year":"2019","unstructured":"Varasteh Z, Mohanta S, Robu S, Braeuer M, Li Y, Omidvari N, et al. Molecular imaging of fibroblast activity after myocardial infarction using a 68Ga-labeled fibroblast activation protein inhibitor, FAPI-04. J Nucl Med. 2019;60:1743\u20139.","journal-title":"J Nucl Med"},{"key":"778_CR18","doi-asserted-by":"publisher","first-page":"7755","DOI":"10.7150\/thno.51419","volume":"11","author":"LBN Langer","year":"2021","unstructured":"Langer LBN, Hess A, Korkmaz Z, Tillmanns J, Reffert LM, Bankstahl JP, et al. Molecular imaging of fibroblast activation protein after myocardial infarction using the novel radiotracer [68Ga]MHLL1. Theranostics. 2021;11:7755\u201366.","journal-title":"Theranostics."},{"key":"778_CR19","doi-asserted-by":"publisher","first-page":"4171","DOI":"10.1021\/acs.molpharmaceut.2c00551","volume":"19","author":"P Qiao","year":"2022","unstructured":"Qiao P, Wang Y, Zhu K, Zheng D, Song Y, Jiang D, et al. Noninvasive monitoring of reparative fibrosis after myocardial infarction in rats using68 Ga-FAPI-04 PET\/CT. Mol Pharm. 2022;19:4171\u20138.","journal-title":"Mol Pharm"},{"key":"778_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2024.101340","volume":"50","author":"J Kupusovic","year":"2024","unstructured":"Kupusovic J, Kessler L, Kazek S, Chodyla MK, Umutlu L, Zarrad F, et al. Delayed 68Ga-FAPI-46 PET\/MR imaging confirms ongoing fibroblast activation in patients after acute myocardial infarction. IJC Heart Vasc. 2024;50: 101340.","journal-title":"IJC Heart Vasc"},{"key":"778_CR21","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.jacc.2024.10.103","volume":"85","author":"AK Barton","year":"2025","unstructured":"Barton AK, Craig NJ, Loganath K, Joshi S, Tsampasian V, Mahendran M, et al. Myocardial fibroblast activation after acute myocardial infarction: a positron emission tomography and magnetic resonance study. J Am Coll Cardiol. 2025;85:578\u201391.","journal-title":"J Am Coll Cardiol"},{"key":"778_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.nuclcard.2024.101910","volume":"38","author":"C Hua","year":"2024","unstructured":"Hua C, Xi X-Y, Zhang Y, Suo N, Tu B, Liu Y, et al. 99mTc-HFAPi SPECT imaging predicts left ventricular remodeling after acute myocardial infarction. J Nucl Cardiol. 2024;38: 101910.","journal-title":"J Nucl Cardiol"},{"key":"778_CR23","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1053\/j.semnuclmed.2024.05.007","volume":"54","author":"R Kazimierczyk","year":"2024","unstructured":"Kazimierczyk R, Kaminski KA, Nekolla SG. Cardiac PET\/MRI: recent developments and future aspects. Semin Nucl Med. 2024;54:733\u201346.","journal-title":"Semin Nucl Med"},{"key":"778_CR24","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.cpet.2020.06.007","volume":"15","author":"R Cardoso","year":"2020","unstructured":"Cardoso R, Leucker TM. Applications of PET-MR imaging in cardiovascular disorders. PET Clin. 2020;15:509\u201320.","journal-title":"PET Clin."},{"key":"778_CR25","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s41824-018-0050-2","volume":"3","author":"C Rischpler","year":"2019","unstructured":"Rischpler C, Nekolla SG, Heusch G, Umutlu L, Rassaf T, Heusch P, et al. Cardiac PET\/MRI\u2014an update. Eur J Hybrid Imaging. 2019;3:2.","journal-title":"Eur J Hybrid Imaging."},{"key":"778_CR26","doi-asserted-by":"publisher","unstructured":"Joshi SS, Geers J, Gimelli A, Hyafil F, Habib G, Erba P, et al. Current and emerging radiotracers in molecular cardiovascular imaging. Circ Cardiovasc Imaging [Internet]. 2024 [cited 2024 Dec 14];17. https:\/\/doi.org\/10.1161\/CIRCIMAGING.123.016323.","DOI":"10.1161\/CIRCIMAGING.123.016323"},{"key":"778_CR27","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/01.rlu.0000233082.89996.3a","volume":"31","author":"L Filippi","year":"2006","unstructured":"Filippi L, Biancone L, Petruzziello C, Schillaci O. Tc-99m HMPAO-labeled leukocyte scintigraphy with hybrid SPECT\/CT detects perianal fistulas in Crohn disease. Clin Nucl Med. 2006;31:541\u20132.","journal-title":"Clin Nucl Med"},{"key":"778_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2024.132545","volume":"417","author":"K Holcman","year":"2024","unstructured":"Holcman K, Z\u0105bek A, Boczar K, Rubi\u015b P, \u0106miel B, Szot W, et al. The [99mTc]Tc-HMPAO-labelled white blood cell SPECT\/CT as a novel criterion for infective endocarditis diagnosis. Int J Cardiol. 2024;417: 132545.","journal-title":"Int J Cardiol"},{"key":"778_CR29","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000040175","volume":"103","author":"F Zhao","year":"2024","unstructured":"Zhao F, Chen Y, Zhao J, Pang Z, Wang J, Cao B, et al. Impact of CT attenuation correction on viable myocardium detection in combined SPECT and PET\/CT: a retrospective cohort study. Medicine. 2024;103: e40175.","journal-title":"Medicine"},{"key":"778_CR30","doi-asserted-by":"publisher","DOI":"10.1172\/JCI148554","volume":"132","author":"JG Travers","year":"2022","unstructured":"Travers JG, Tharp CA, Rubino M, McKinsey TA. Therapeutic targets for cardiac fibrosis: from old school to next-gen. J Clin Invest. 2022;132: e148554.","journal-title":"J Clin Invest"}],"container-title":["Molecular Diagnosis & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-025-00778-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40291-025-00778-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-025-00778-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T08:15:45Z","timestamp":1751616945000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40291-025-00778-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["778"],"URL":"https:\/\/doi.org\/10.1007\/s40291-025-00778-6","relation":{},"ISSN":["1177-1062","1179-2000"],"issn-type":[{"value":"1177-1062","type":"print"},{"value":"1179-2000","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,22]]},"assertion":[{"value":"9 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Open access funding provided by Universit\u00e0 degli Studi di Roma Tor Vergata within the CRUI-CARE Agreement.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"L.F., M.A.P., and O.S. have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent (participation and publication)"}},{"value":"Data sharing is not applicable to this article as no datasets were generated or analyzed.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Conceptualization: L.F. and O.S.; writing first draft: L.F. and M.A.P.; editing and revision: L.F., M.A.P., and O.S. All authors read and approved the final version of the manuscript.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}